Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy

Bibliography

• Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med 2008;3:1-5
   PubMed Web of Science ®Google Scholar
• Badiavas EV, Abedi M, Butmarc J, et al. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003;196:245-50
   PubMed Web of Science ®Google Scholar
• Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Med 2011;9(1):52
   PubMed Web of Science ®Google Scholar
• Lunn JS, Sakowski SA, Hur J, Feldman EL. Stem cell technology for neurodegenerative diseases. Ann Neurol 2011;70(3):353-61
   PubMed Web of Science ®Google Scholar
• Volarevic V, Bojic S, Nurkovic J, et al. Stem cells as new agents for the treatment of infertility: current and future perspectives and challenges. BioMed Res Int 2014;2014:507234
   PubMed Web of Science ®Google Scholar
• Dittmar T, Zänker KS. Role of cancer stem cells in cancer biology and therapy. CRC Press. Taylor & Francis Group; 2013
   Google Scholar
• Jones DL, Wagers AJ. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol 2008;9(1):11-21
   PubMed Web of Science ®Google Scholar
• Scadden DT. The stem-cell niche as an entity of action. Nature 2006;441(7097):1075-9
   PubMed Web of Science ®Google Scholar
• Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007;129(3):465-72
   PubMed Web of Science ®Google Scholar
• Haque N, Rahman MT, Abu Kasim NH, Alabsi AM. Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. ScientificWorldJournal 2013;2013:632972
   PubMed Web of Science ®Google Scholar
• Panchision DM. The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 2009;220:562-8
   PubMed Web of Science ®Google Scholar
• Estrada JC, Albo C, Benguría A, et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ 2012;19:743-55
   PubMed Web of Science ®Google Scholar
• Fehrer C, Brunauer R, Laschober G, et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007;6:745-57
   PubMed Web of Science ®Google Scholar
• Jin Y, Kato T, Furu M, et al. Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase. Biochem Biophys Res Commun 2010;391:1471-6
   PubMed Web of Science ®Google Scholar
• Mohyeldin A, Garzón-Muvdi T, Quiñones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 2010;7:150-61
   PubMed Web of Science ®Google Scholar
• Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001;22:201-7
   PubMed Web of Science ®Google Scholar
• Yu Q, Liu L, Lin J, et al. SDF-1alpha/CXCR4 axis mediates the migration of mesenchymal stem cells to the hypoxic-ischemic brain lesion in a rat model. Cell J 2015;16:440-7
   PubMed Web of Science ®Google Scholar
• Kang SK, Shin IS, Ko MS, et al. Journey of mesenchymal stem cells for homing: Strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int 2012;2012
   Google Scholar
• Liu H, Liu S, Li Y, et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One 2012;7:e34608
   PubMed Web of Science ®Google Scholar
• Rosova I, Dao M, Capoccia B, et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008;26:2173-82
   PubMed Web of Science ®Google Scholar
• Gao Q, Guo M, Zeng W, et al. Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro. Stem Cells Int 2015;2015:836390
   PubMed Web of Science ®Google Scholar
• Stamati K, Mudera V, Cheema U. Evolution of oxygen utilization in multicellular organisms and implications for cell signalling in tissue engineering. J Tissue Eng 2011;2(1):2041731411432365
   Google Scholar
• Semenza GL. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today 2007;12(19):853-9
   PubMed Web of Science ®Google Scholar
• Zhu L-L, Wu L-Y, Yew DT, Fan M. Effects of hypoxia on the proliferation and differentiation of NSCs. Mol Neurobiol 2005;31(1-3):231-42
   PubMed Web of Science ®Google Scholar
• Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006;70(5):1469-80
   PubMed Web of Science ®Google Scholar
• Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005;105(2):659-69
   PubMed Web of Science ®Google Scholar
• Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12(12):5447-54
   PubMed Web of Science ®Google Scholar
• Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270(3):1230-7
   PubMed Web of Science ®Google Scholar
• Weidemann A, Johnson R. Biology of HIF-1alpha. Cell Death Differ 2008;15(4):621-7
   PubMed Web of Science ®Google Scholar
• Nagy M. HIF-1 is the commander of gateways to cancer. J Cancer Sci Ther 2010
   Google Scholar
• Xia Y, Choi H-K, Lee K. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Eur J Med Chem 2012;49:24-40
   PubMed Web of Science ®Google Scholar
• Fujita N, Markova D, Anderson DG, et al. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc distinct roles of PHD2 and PHD3 proteins in controlling HIF-1alpha activity in hypoxia. J Biol Chem 2012;287(20):16975-86
   PubMed Web of Science ®Google Scholar
• Menrad H, Werno C, Schmid T, et al. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids. Hepatology 2010;51(6):2183-92
   PubMed Web of Science ®Google Scholar
• Lappin T. Dual control: the HIF-2 regulator. Blood 2010;116(16):2870-1
   PubMed Web of Science ®Google Scholar
• Bao W, Qin P, Needle S, et al. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat. J Cardiovasc Pharmacol 2010;56(2):147-55
   PubMed Web of Science ®Google Scholar
• Kant R, Bali A, Singh N, Jaggi AS. Prolyl 4 hydroxylase: a critical target in the pathophysiology of diseases. Korean J Physiol Pharmacol 2013;17(2):111-20
   PubMed Web of Science ®Google Scholar
• Karuppagounder SS, Ratan RR. Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? J Cereb Blood Flow Metab 2012;32(7):1347-61
   PubMed Web of Science ®Google Scholar
• Acevedo JM, Centanin L, Dekanty A, Wappner P. Oxygen sensing in Drosophila: multiple isoforms of the prolyl hydroxylase fatiga have different capacity to regulate HIFalpha/Sima. PLoS One 2010;5(8):e12390
   Google Scholar
• Jaakkola P, Mole DR, Tian Y-M, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292(5516):468-72
   PubMed Web of Science ®Google Scholar
• Siddiq A, Aminova LR, Ratan RR. Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochem Res 2007;32(4-5):931-46
   PubMed Web of Science ®Google Scholar
• Steinhoff A, Pientka FK, Möckel S, et al. Cellular oxygen sensing: Importins and exportins are mediators of intracellular localisation of prolyl-4-hydroxylases PHD1 and PHD2. Biochem Biophys Res Commun 2009;387(4):705-11
   PubMed Web of Science ®Google Scholar
• Tian Y, Mole D, Ratcliffe P, Gleadle J. Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation. Biochem J 2006;397:179-86
   PubMed Web of Science ®Google Scholar
• Metzen E, Berchner-Pfannschmidt U, Stengel P, et al. Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J Cell Sci 2003;116(7):1319-26
   PubMed Web of Science ®Google Scholar
• Lieb ME, Menzies K, Moschella MC, et al. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol 2002;80(4):421-6
   PubMed Web of Science ®Google Scholar
• Place TL, Domann FE. Prolyl-hydroxylase 3: evolving roles for an ancient signaling protein. Hypoxia 2013;2013(1):13-17
   PubMedGoogle Scholar
• Xie L, Pi X, Mishra A, et al. PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response. J Clin Invest 2012;122(8):2827-36
   PubMed Web of Science ®Google Scholar
• Smirnova N, Hushpulian D, Speer R, et al. Catalytic mechanism and substrate specificity of HIF prolyl hydroxylases. Biochem (Moscow) 2012;77(10):1108-19
   PubMed Web of Science ®Google Scholar
• Moser SC, Bensaddek D, Ortmann B, et al. PHD1 links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein Cep192. Dev Cell 2013;26(4):381-92
   PubMed Web of Science ®Google Scholar
• Fong G, Takeda K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ 2008;15(4):635-41
   PubMed Web of Science ®Google Scholar
• Fan L, Li J, Yu Z, et al. The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration. BioMed Res Int 2014;2014
   Google Scholar
• Siddiq A, Aminova LR, Ratan RR. Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and neuroprotection. Front Biosci 2008;13:2875-87
   PubMed Web of Science ®Google Scholar
• Guo M, Song L-P, Jiang Y, et al. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms. Apoptosis 2006;11(1):67-77
   PubMed Web of Science ®Google Scholar
• Hien LS. Induction of Angiogenesis in Microfluidics by using Prolyl Hydroxylase Inhibitor and Sphingosine I-Phosphate. 2013
   Google Scholar
• Miyata T, Takizawa S, de Strihou CVY. Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets. Am J Physiol Cell Physiol 2011;300(2):C226-C31
   Google Scholar
• Kontani S, Nagata E, Uesugi T, et al. A novel prolyl hydroxylase inhibitor protects against cell death after hypoxia. Neurochem Res 2013;38(12):2588-94
   PubMed Web of Science ®Google Scholar
• Jokilehto T, Jaakkola PM. The role of HIF prolyl hydroxylases in tumour growth. J Cell Mol Med 2010;14(4):758-70
   PubMed Web of Science ®Google Scholar
• Warnecke C, Griethe W, Weidemann A, et al. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB J 2003;17(9):1186-8
   PubMed Web of Science ®Google Scholar
• Sefcik LS, Petrie Aronin CE, Botchwey EA. Engineering vascularized tissues using natural and synthetic small molecules. Organogenesis 2008;4(4):215-27
   PubMedGoogle Scholar
• Fraisl P, Aragonés J, Carmeliet P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 2009;8(2):139-52
   PubMed Web of Science ®Google Scholar
• Warshakoon NC, Wu S, Boyer A, et al. Design and synthesis of a series of novel pyrazolopyridines as HIF 1-alpha prolyl hydroxylase inhibitors. Bioorg Med Chem Lett 2006;16(21):5687-90
   PubMed Web of Science ®Google Scholar
• Natarajan R, Salloum FN, Fisher BJ, Kukreja RC. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 2006;98(1):133-40
   PubMed Web of Science ®Google Scholar
• Myllyharju J. Prolyl 4-hydroxylases, master regulators of the hypoxia response. Acta Physiologica 2013;208(2):148-65
   PubMed Web of Science ®Google Scholar
• Grigioni F, Detaint D, Avierinos J-F, et al. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol 2005;45(2):260-7
   PubMed Web of Science ®Google Scholar
• Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000;287(5457):1442-6
   PubMed Web of Science ®Google Scholar
• Shi R-Z, Li Q-P. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease. Biochem Biophys Res Commun 2008;376(2):247-50
   PubMed Web of Science ®Google Scholar
• Nagaya N, Fujii T, Iwase T, et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004;287(6):H2670-H6
   PubMed Web of Science ®Google Scholar
• Tang YL, Tang Y, Zhang YC, et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005;46(7):1339-50
   PubMed Web of Science ®Google Scholar
• Srijaya TC, Ramasamy TS, Kasim NHA. Advancing stem cell therapy from bench to bedside: lessons from drug therapies. J Transl Med 2014;12(1):243
   PubMed Web of Science ®Google Scholar
• Liu XB, Wang JA, Ogle ME, Wei L. Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival. J Cell Biochem 2009;106(5):903-11
   PubMed Web of Science ®Google Scholar
• Liu X, Wang J-A, Ji X-Y, et al. Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats. Stem Cell Res Ther 2014;5(5):111
   PubMed Web of Science ®Google Scholar
• Dai Y, Xu M, Wang Y, et al. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 2007;42(6):1036-44
   PubMed Web of Science ®Google Scholar
• Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95(9):911-21
   PubMed Web of Science ®Google Scholar
• Chimenti I, Gaetani R, Barile L, et al. Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts. Methods Mol Biol 2012;327-38
   PubMedGoogle Scholar
• Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115(7):896-908
   PubMed Web of Science ®Google Scholar
• Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012;379(9819):895-904
   PubMed Web of Science ®Google Scholar
• Hsiao L-C, Carr C, Chang K-C, et al. Stem cell-based therapy for ischemic heart disease. Cell Transplant 2013;22(4):663-75
   PubMed Web of Science ®Google Scholar
• Tan SC, Gomes R, Yeoh KK, et al. Preconditioning of cardiosphere-derived cells with hypoxia or prolyl-4-hydroxylase inhibitors increases stemness and decreases reliance on oxidative metabolism. Cell Transplant 2015. [Epub ahead of print]
   Google Scholar
• Tan S CC, Yeoh K. Abstract P027: preconditioning cardiosphere-derived cells by hypoxia and prolyl hydroxylase inhibitors to induce hif-related metabolic changes and C-kit expression. Circ Res 2011;109:AP027
   Google Scholar
• Wang WE, Yang D, Li L, et al. Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium. Circ Res 2013;113(3):288-300
   PubMed Web of Science ®Google Scholar
• Végran F, Boidot R, Michiels C, et al. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis. Cancer Res 2011;71(7):2550-60
   PubMed Web of Science ®Google Scholar
• Hynes B, Kumar AH, O’Sullivan J, et al. Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1. Eur Heart J 2013;34(10):782-9
   PubMed Web of Science ®Google Scholar
• Mehrhof FB, Müller F-U, Bergmann MW, et al. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation 2001;104(17):2088-94
   PubMed Web of Science ®Google Scholar
• Padin-Iruegas ME, Misao Y, Davis ME, et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 2009;120(10):876-87
   PubMed Web of Science ®Google Scholar
• Huang M, Nguyen P, Jia F, et al. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation 2011;124(11 suppl 1):S46-54
   Google Scholar
• Kurozumi K, Nakamura K, Tamiya T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005;11(1):96-104
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32(4):1005-11
   PubMed Web of Science ®Google Scholar
• Pacary E, Legros H, Valable S, et al. Synergistic effects of CoCl2 and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J Cell Sci 2006;119(13):2667-78
   PubMed Web of Science ®Google Scholar
• Jeon ES, Shin JH, Hwang SJ, et al. Cobalt chloride induces neuronal differentiation of human mesenchymal stem cells through upregulation of microRNA-124a. Biochem Biophys Res Commun 2014;444(4):581-7
   PubMed Web of Science ®Google Scholar
• Cheng L-C, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009;12(4):399-408
   PubMed Web of Science ®Google Scholar
• Kulshreshtha R, Ferracin M, Wojcik SE, et al. A microRNA signature of hypoxia. Mol Cell Biol 2007;27(5):1859-67
   PubMed Web of Science ®Google Scholar
• Bito H, Furuyashiki T, Ishihara H, et al. A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons. Neuron 2000;26(2):431-41
   PubMed Web of Science ®Google Scholar
• Luo L. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000;1(3):173-80
   PubMed Web of Science ®Google Scholar
• Goda N, Ryan HE, Khadivi B, et al. Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003;23(1):359-69
   PubMed Web of Science ®Google Scholar
• Milosevic J, Adler I, Manaenko A, et al. Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): Relevance in neural progenitor/stem cells. Neurotox Res 2009;15(4):367-80
   PubMed Web of Science ®Google Scholar
• Chu K, Jung K-H, Kim S-J, et al. Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain. Brain Res 2008;1207:182-92
   PubMed Web of Science ®Google Scholar
• Robin AM, Zhang ZG, Wang L, et al. Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 2006;26(1):125-34
   PubMed Web of Science ®Google Scholar
• Luo Y, Cai J, Xue H, et al. Functional SDF1alpha/CXCR4 signaling in the developing spinal cord. J Neurochem 2005;93(2):452-62
   PubMed Web of Science ®Google Scholar
• Jin K, Zhu Y, Sun Y, et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci 2002;99(18):11946-50
   PubMed Web of Science ®Google Scholar
• Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004;279(41):42351-4
   PubMed Web of Science ®Google Scholar
• Nanji SA, Shapiro A. Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab 2006;8(1):15-25
   PubMed Web of Science ®Google Scholar
• Urban VS, Kiss J, Kovacs J, et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008;26(1):244-53
   PubMed Web of Science ®Google Scholar
• Najafi R, Sharifi AM. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert Opin Biol Ther 2013;13(7):959-72
   PubMed Web of Science ®Google Scholar
• Van Linthout S, Stamm C, Schultheiss H-P, Tschöpe C. Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond. Cardiol Res Pract 2011;2011:757154
   PubMedGoogle Scholar
• Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30(9):973-81
   PubMed Web of Science ®Google Scholar
• Langlois A, Bietiger W, Mandes K, et al. Overexpression of vascular endothelial growth factor in vitro using deferoxamine: a new drug to increase islet vascularization during transplantation. Transplant Proc 2008;40(2):473-6
   PubMed Web of Science ®Google Scholar
• Vaithilingam V, Oberholzer J, Guillemin G, Tuch B. Beneficial effects of desferrioxamine on encapsulated human islets – in vitro and in vivo study. Am J Transplant 2010;10(9):1961-9
   PubMed Web of Science ®Google Scholar
• Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vas Surg 2010;51(1):230-41
   PubMed Web of Science ®Google Scholar
• Ebrahimian TG, Heymes C, You D, et al. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 2006;169(2):719-28
   PubMed Web of Science ®Google Scholar
• HoWangYin K-Y, Loinard C, Bakker W, et al. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia. Stem Cells 2014;32(1):231-43
   PubMed Web of Science ®Google Scholar
• Li H, Zuo S, He Z, et al. Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival. Am J Physiol Heart Circ Physiol 2010;299(6):H1772-H81
   Web of Science ®Google Scholar
• Deuse T, Peter C, Fedak PW, et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell–based myocardial salvage after acute myocardial infarction. Circulation 2009;120(11 suppl 1):S247-S54
   Google Scholar
• Sasso FC, Torella D, Carbonara O, et al. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol 2005;46(5):827-34
   PubMed Web of Science ®Google Scholar
• Rey S, Lee K, Wang CJ, et al. Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci 2009;106(48):20399-404
   PubMed Web of Science ®Google Scholar
• Bauer TW, Muschler GF. Bone graft materials: an overview of the basic science. Clin Orthop Relat Res 2000;371:10-27
   PubMed Web of Science ®Google Scholar
• Mariner PD, Wudel JM, Miller DE, et al. Synthetic hydrogel scaffold is an effective vehicle for delivery of INFUSE (rhBMP2) to critical-sized calvaria bone defects in rats. J Orthop Res 2013;31(3):401-6
   PubMed Web of Science ®Google Scholar
• Jo S, Kim S, Cho TH, et al. Effects of recombinant human bone morphogenic protein-2 and human bone marrow-derived stromal cells on in vivo bone regeneration of chitosan–poly (ethylene oxide) hydrogel. J Biomed Mater Res A 2013;101(3):892-901
   PubMed Web of Science ®Google Scholar
• Zhang W, Li G, Deng R, et al. New bone formation in a true bone ceramic scaffold loaded with desferrioxamine in the treatment of segmental bone defect: a preliminary study. J Orthop Sci 2012;17(3):289-98
   PubMed Web of Science ®Google Scholar
• Dudas JR, Marra KG, Cooper GM, et al. The osteogenic potential of adipose-derived stem cells for the repair of rabbit calvarial defects. Ann Plast Surg 2006;56(5):543-8
   PubMed Web of Science ®Google Scholar
• Cowan CM, Shi Y-Y, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22(5):560-7
   PubMed Web of Science ®Google Scholar
• Riddle RC, Khatri R, Schipani E, Clemens TL. Role of hypoxia-inducible factor-1alpha in angiogenic–osteogenic coupling. J Mol Med 2009;87(6):583-90
   PubMed Web of Science ®Google Scholar
• Wu C, Zhou Y, Chang J, Xiao Y. Delivery of dimethyloxallyl glycine in mesoporous bioactive glass scaffolds to improve angiogenesis and osteogenesis of human bone marrow stromal cells. Acta Biomater 2013;9(11):9159-68
   PubMed Web of Science ®Google Scholar
• Wagegg M, Gaber T, Lohanatha FL, et al. Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner. PLoS One 2012;7(9):e46483
   PubMed Web of Science ®Google Scholar
• Ding H, Chen S, Song W-Q, et al. Dimethyloxaloylglycine improves angiogenic activity of bone marrow stromal cells in the tissue-engineered bone. Int J Biol Sci 2014;10(7):746-56
   PubMed Web of Science ®Google Scholar
• Ding H, Gao Y-S, Wang Y, et al. Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential. Stem Cells Dev 2013;23(9):990-1000
   Web of Science ®Google Scholar
• Wan C, Gilbert SR, Wang Y, et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci 2008;105(2):686-91
   PubMed Web of Science ®Google Scholar
• Shen X, Wan C, Ramaswamy G, et al. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res 2009;27(10):1298-305
   PubMed Web of Science ®Google Scholar
• Stewart R, Goldstein J, Eberhardt A, et al. Increasing vascularity to improve healing of a segmental defect of the rat femur. J Orthop Trauma 2011;25(8):472-6
   PubMed Web of Science ®Google Scholar
• Qu Z-H, Zhang X-L, Tang T-T, Dai K-R. Promotion of osteogenesis through beta-catenin signaling by desferrioxamine. Biochem Biophys Res Commun 2008;370(2):332-7
   PubMed Web of Science ®Google Scholar
• Genetos DC, Toupadakis CA, Raheja LF, et al. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J Cell Biochem 2010;110(2):457-67
   PubMed Web of Science ®Google Scholar
• Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005;8(5):739-50
   PubMed Web of Science ®Google Scholar
• Du J, Liu L, Lay F, et al. Combination of HIF-1alpha gene transfection and HIF-1-activated bone marrow-derived angiogenic cell infusion improves burn wound healing in aged mice. Gene Ther 2013;20(11):1070-6
   PubMed Web of Science ®Google Scholar
• Zhang X, Sarkar K, Rey S, et al. Aging impairs the mobilization and homing of bone marrow-derived angiogenic cells to burn wounds. J Mol Med 2011;89(10):985-95
   PubMed Web of Science ®Google Scholar
• Zhang X, Yan X, Cheng L, et al. Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. PLoS One 2013;8(12):e84548
   PubMed Web of Science ®Google Scholar
• Takaku M, Tomita S, Kurobe H, et al. Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells. PLoS One 2012;7(8):42964
   PubMed Web of Science ®Google Scholar
• Seo B-M, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364(9429):149-55
   PubMed Web of Science ®Google Scholar
• Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci 2000;97(25):13625-30
   PubMed Web of Science ®Google Scholar
• Murakami Y, Kojima T, Nagasawa T, et al. Novel isolation of alkaline phosphatase-positive subpopulation from periodontal ligament fibroblasts. J Periodontol 2003;74(6):780-6
   PubMed Web of Science ®Google Scholar
• Isaka J, Ohazama A, Kobayashi M, et al. Participation of periodontal ligament cells with regeneration of alveolar bone. J Periodontol 2001;72(3):314-23
   PubMed Web of Science ®Google Scholar
• Osathanon T, Vivatbutsiri P, Sukarawan W, et al. Cobalt chloride supplementation induces stem-cell marker expression and inhibits osteoblastic differentiation in human periodontal ligament cells. Archives Oral Biol 2015;60(1):29-36
   PubMed Web of Science ®Google Scholar
• Müller H-D, Cvikl B, Gruber R, et al. Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor in dental pulp–derived cells. J Endod 2012;38(11):1498-503
   PubMed Web of Science ®Google Scholar
• Liu W, Xu J, Wang M, et al. Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway. Int J Oncol 2011;39(5):1213-20
   PubMed Web of Science ®Google Scholar
• Kimbro K, Simons J. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr-Relat Cancer 2006;13(3):739-49
   PubMed Web of Science ®Google Scholar
• Cheng Z-X, Wang D-W, Liu T, et al. Effects of the HIF-1alpha and NF-kappaB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells. Oncol Rep 2014;31(4):1891-8
   PubMed Web of Science ®Google Scholar
• Huang L, Ao Q, Zhang Q, et al. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha. J Cancer Res Clin Oncol 2010;136(3):447-56
   PubMed Web of Science ®Google Scholar
• Bonios M, Chang CY, Terrovitis J, et al. Constitutive HIF-1alpha expression blunts the beneficial effects of cardiosphere-derived cell therapy in the heart by altering paracrine factor balance. J Cardiovasc Transl Res 2011;4(3):363-72
   PubMed Web of Science ®Google Scholar
• Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332(6163):411-15
   PubMed Web of Science ®Google Scholar
• Hocher B, George I, Rebstock J, et al. Endothelin system–dependent cardiac remodeling in renovascular hypertension. Hypertension 1999;33(3):816-22
   PubMed Web of Science ®Google Scholar
• Rebsamen M, Church D, Morabito D, et al. Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes. Am J Physiol 1997;273(5):E922-E31
   Google Scholar
• Loboda A, Jozkowicz A, Dulak J. HIF-1 versus HIF-2—Is one more important than the other? Vascul Pharmacol 2012;56(5):245-51
   PubMed Web of Science ®Google Scholar
• Holmquist-Mengelbier L, Fredlund E, Löfstedt T, et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 2006;10(5):413-23
   PubMed Web of Science ®Google Scholar
• Scrideli CA, Carlotti Jr CG, Mata JF, et al. Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas. J Neuro-Oncol 2007;83(3):233-9
   PubMed Web of Science ®Google Scholar
• Bordji K, Grandval A, Cuhna-Alves L, et al. Hypoxia-inducible factor-2alpha (HIF-2alpha), but not HIF-1alpha, is essential for hypoxic induction of class III beta-tubulin expression in human glioblastoma cells. FEBS J 2014;281(23):5220-36
   PubMed Web of Science ®Google Scholar
• Koh MY, Powis G. Passing the baton: the HIF switch. Trends Biochem Sci 2012;37(9):364-72
   PubMed Web of Science ®Google Scholar
• Zhang T, Niu X, Liao L, et al. The contributions of HIF-target genes to tumor growth in RCC. PLoS One 2013;8(11):e80544
   PubMed Web of Science ®Google Scholar
• Carroll VA, Ashcroft M. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2beta in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res 2006;66(12):6264-70
   PubMed Web of Science ®Google Scholar
• Qing G, Simon MC. Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes. Curr Opin Genet Dev 2009;19(1):60-6
   PubMed Web of Science ®Google Scholar
• Zhao J, Du F, Luo Y, et al. The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors. Cancer Treat Rev 2015;41(7):623-33
   PubMed Web of Science ®Google Scholar
• Xiang L, Liu Z-H, Huan Q, et al. Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinoma. Diagn Pathol 2012;7:32
   PubMed Web of Science ®Google Scholar
• Ginouves A, Ilc K, Macías N, et al. PHDs overactivation during chronic hypoxia “desensitizes” HIFalpha and protects cells from necrosis. Proc Natl Acad Sci 2008;105(12):4745-50
   PubMed Web of Science ®Google Scholar
• Yu J, Yin S, Zhang W, et al. Hypoxia preconditioned bone marrow mesenchymal stem cells promoted liver regeneration in a rat massive hepatectomy model. Stem Cell Res Ther 2013;4(4):83
   PubMed Web of Science ®Google Scholar
• Yan F, Yao Y, Chen L, et al. Hypoxic preconditioning improves survival of cardiac progenitor cells: Role of stromal cell derived factor-1alpha–CXCR4 axis. PLoS One 2012;7(7):e37948
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu L, Huo Y, et al. Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities. BioMed Res Int 2014;2014:462472
   PubMed Web of Science ®Google Scholar
• Sun B, Guo S, Xu F, et al. Concentrated hypoxia-preconditioned adipose mesenchymal stem cell-conditioned medium improves wounds healing in full-thickness skin defect model. Int Scholarly Res Notices 2014;2014
   Google Scholar
• Jun EK, Zhang Q, Yoon BS, et al. Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-beta/SMAD2 and PI3K/Akt pathways. Int J Mol Sci 2014;15(1):605-28
   PubMed Web of Science ®Google Scholar
• Chang C-P, Chio C-C, Cheong C-U, et al. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci 2013;124(3):165-76
   PubMed Web of Science ®Google Scholar
• Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109(10):1292-8
   PubMed Web of Science ®Google Scholar
• Liu J, Wang Y, Du W, Yu B. Sca-1-positive cardiac stem cell migration in a cardiac infarction model. Inflammation 2013;36(3):738-49
   PubMed Web of Science ®Google Scholar
• Ghaffaripour HA, Jalali M, Nikravesh MR, et al. Neuronal cell reconstruction with umbilical cord blood cells in the brain hypoxia-ischemia. Iran Biomed J 2015;19(1):29-34
   PubMedGoogle Scholar
• Jian K, Shi Y, Zhang Y, et al. Time course effect of hypoxia on bone marrow-derived endothelial progenitor cells and their effects on left ventricular function after transplanted into acute myocardial ischemia rat. Eur Rev Med Pharmacol Sci 2015;19(6):1043-54
   PubMed Web of Science ®Google Scholar
• Rosova I, Dao M, Capoccia B, et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008;26(8):2173-82
   PubMed Web of Science ®Google Scholar
• Beegle J, Lakatos K, Kalomoiris S, et al. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells 2015;33(6):1818-28
   PubMed Web of Science ®Google Scholar
• Sun J, Wei ZZ, Gu X, et al. Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice. Exp Neurol 2015. [ Epub ahead of print]
   Web of Science ®Google Scholar